Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,589 | 9,750 | 11,478 | 14,364 | 21,472 |
| TOTAL | $8,091 | $10,603 | $12,507 | $14,873 | $22,230 |
| Non-Current Assets | |||||
| PPE Net | 30 | 37 | 109 | 133 | 151 |
| Other Non-Current Assets | 93 | 93 | 200 | 200 | 200 |
| TOTAL | $123 | $130 | $309 | $333 | $351 |
| Total Assets | $8,214 | $10,733 | $12,817 | $15,206 | $22,580 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 1,190 |
| Accounts payable and accrued liabilities | 549 | 955 | 504 | 797 | 1,090 |
| Accrued Expenses | 1,152 | 742 | 399 | 635 | 1,452 |
| TOTAL | $1,701 | $1,698 | $902 | $1,432 | $3,732 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 2,810 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $2,810 |
| Total Liabilities | $1,701 | $1,698 | $902 | $1,432 | $6,542 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1 | 1 | 1 | 1 | 1 |
| Common Shares | 1 | 1 | 0 | 1 | 1 |
| Retained earnings | -131,678 | -128,864 | -125,850 | -123,878 | -121,516 |
| TOTAL | $6,513 | $9,035 | $11,915 | $13,774 | $16,039 |
| Total Liabilities And Equity | $8,214 | $10,733 | $12,817 | $15,206 | $22,581 |